Hip procedures are common orthopedic surgeries performed routinely and are associated with significant amount of pain. Adequate analgesia is very crucial post-operatively to enhance dynamic pain relief, early patient recovery, reduced hospital stay, prevention of readmissions along with overall improved patient satisfaction to recovery. Peripheral nerve blocks have the advantage of potent analgesia, minimal systemic complications which are associated with central neuraxial blockades and less motor blockade, therefore leading to early patient recovery and overall better outcomes. A prospective, double-blinded randomized study will be conducted on 60 adult patients, ASA- I to III undergoing orthopedic surgeries for hip fractures, under sub-arachnoid block in which they will be randomly allocated to either group A which will receive 30ml of 0.2% Ropivacaine with 4mg dexamethasone USG-guided pericapsular nerve group (PENG) block or to group B which will receive 30ml of 0.2% Ropivacaine with 4mg dexamethasone USG-guided supra-inguinal fascia iliaca (SIFI) block. The primary outcome is comparing VAS scores at rest at 24 hours in both the groups. The secondary outcome is functional mobility at 24 and 48 hours postoperatively by assessing the quadriceps muscle strength, maximum weight bearing possible at 24 hours and 48 hours post-operatively, time to need for first rescue analgesia, total opioid consumption in first 24 hours along with overall patient satisfaction to recovery and surgeon’s satisfaction to overall pain management in both the groups.